Drug-labels.com

Halaven: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
0.5 mg
Active ingredient:
ATC code:

Patient Medication Information: uses, side effects, how to take - Halaven

ABOUT THIS MEDICATION

What the medication is used for:

HALAVEN is a cancer medicine. It is sold by prescription.

It is used to treat:

  • breast cancer that has spread to other parts of the body. It is used when you have had two or more cancer drug treatment plans to treat your breast cancer that has spread.

HALAVEN is used to treat adult patients with a type of cancer that starts in fat cells called liposarcoma.

Halaven is used if you:

  • can't have an operation to take the cancer out and have liposarcoma that is advanced or has spread to other parts of the body. And,
  • have had other drugs to treat this.

What it does:

HALAVEN is an anti-cancer agent which works by stopping the growth of cancer cells.

When it should not be used:

Do not use HALAVEN if you are allergic to eribulin mesylate, or halichondrin B, or any drug related to halichondrin B.

What the medicinal ingredient is:

Eribulin mesylate

What the non-medicinal ingredients are:

Alcohol, hydrochloric acid, sodium hydroxide, water for injection.

What dosage forms it comes in:

HALAVEN contains 1.0 mg eribulin mesylate per vial in 2 mL of solution.

WARNINGS AND PRECAUTIONS

Serious Warnings and Precautions

HALAVEN should be prescribed and managed by a doctor experienced in the use of cancer drugs. Serious side effects

with HALAVEN include:

  • Neutropenia (decrease in the number of white blood cells)
  • Abnormal electrical signal of the heart called “prolongation of the QT interval” (changes in heartbeat)
  • HALAVEN has not been studied in patients with severe hepatic (liver) impairment or End Stage Renal Disease (ESRD, a disease of the kidney).

BEFORE you use HALAVEN talk to your doctor or pharmacist about all of your medical conditions, including if you:

  • have low white blood cell counts or low platelet levels
  • have a fever (temperature above 38.1°C) or an infection
  • have heart problems including “prolongation of the QT interval”(changes in heartbeat)
  • experience numbness, tingling or burning in your hands and feet
  • have liver or kidney problems
  • are pregnant or plan to become pregnant. You should not receive HALAVEN during pregnancy because it may harm your unborn baby. Talk with your health professional about how to prevent pregnancy while receiving HALAVEN, as you should use effective contraception during and for at least 3 months after receiving HALAVEN. Tell your health professional right away if you become pregnant or think you are pregnant while receiving HALAVEN

  • are breast feeding. It is not known if HALAVEN passes into breast milk. Breast feeding must be avoided.

HALAVEN may cause drowsiness or tiredness. Do not drive or operate machinery until you know how the medication affects you.

The safety and effectiveness of HALAVEN in patients under 18 years of age have not been established.

INTERACTIONS WITH THIS MEDICATION

Tell your doctor before taking HALAVEN if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.

HALAVEN may interact with the following medications;

  • drugs known to prolong the QT/QTc interval and/or cause torsade de pointes
  • drugs that decrease electrolyte levels

PROPER USE OF THIS MEDICATION

Usual dose: 1.4 mg/m2 body surface area given as an injection into the vein over 2 to 5 minutes on Days 1 and 8 of a 21-day treatment cycle.

Overdose:

In case of drug overdose, contact a health professional, hospital emergency department or regional Poison Control

Centre immediately, even if there are no symptoms.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

Side effects may include:

Very common side effects

  • low white or red blood cell count
  • general weakness
  • fever
  • muscle or joint pain, bone pain
  • headache
  • decreased appetite
  • weight loss
  • shortness of breath
  • cough
  • blisters or sores of the inside of the mouth
  • back pain

Common side effects

  • dizziness, vertigo
  • skin rash, itchiness
  • high or low blood pressure
  • anxiety, depression, trouble sleeping
  • watery eyes
  • dry mouth
  • stomach upset, heartburn
  • chills
  • upper respiratory tract infections (cough, sore throat, runny nose)
  • weight gain
  • changed sense of taste
  • numbness
  • sore throat
  • fast heart rate
  • hoarse voice
  • pain when passing urine
  • sleepiness

HALAVEN can cause abnormal blood test results. These include changes in bone marrow function tests (white blood cell count, red blood cell count and platelet count), salt levels in the blood (including potassium, calcium, magnesium, phosphorus and sodium), liver enzymes (called AST, ALT, and alkaline phosphatase), protein, bile pigment (bilirubin) and other blood tests such as blood sugar and lactate dehydrogenase (LDH). Your doctor will decide when to perform test and will interpret the results.

SERIOUS SIDE EFFECTS, HOW OFTEN THEY HAPPEN AND WHAT TO DO ABOUT THEM
Symptom / effectTalk to your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases

VERY COMMON

Tiredness

X
Hair lossX
Nausea, vomiting, constipationX

Peripheral neuropathy:

Numbness, tingling, or burning in hands and feet

X
DiarrheaX
Urinary tract infection: fever, chills, burning, pain or difficulty urinatingX

Peripheral edema:

Swelling of hands, feet, or limbs

X
Belly pain or bloatingX

COMMON

Febrile neutropenia:

Infection (fever, chills, cough) when your white blood cell count is low.

X
Thrombocytopenia (low numbers of platelets that are in the blood. These cells help blood to clot): bruising or taking longer to stop bleeding.X
Muscle spasms or weaknessX
Prolongation of the QT interval: Changed heart beatX
Dehydration: feeling thirsty, tired, lightheaded, dry mouth, dark coloured urine and passing urine less often than normal.X
SERIOUS SIDE EFFECTS, HOW OFTEN THEY HAPPEN AND WHAT TO DO ABOUT THEM
Symptom / effectTalk to your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases
Hyperglycaemia (high blood sugar): passing urine a lot, thirst and hunger.X
Pulmonary embolism (blood clot on the lung): chest pain, shortness of breath, coughing up blood.X

UNCOMMON

Allergic reaction: rash, hives, swelling of the face, lips, tongue or throat, difficulty swallowing or breathing.

X

Hepatotoxicity (liver damage): belly pain, yellowing of the skin or whites of the eyes, itching.

Nausea, vomiting and loss of appetite.

X
Renal failure (kidneys not working): causing tiredness, not passing urine, swelling in the legs, confusion.X
Deep vein thrombosis (blood clot in the leg): pain, swelling, redness in the leg.X

RARE

Pancreatitis (inflammation of the pancreas): severe pain in the upper part of the belly with nausea and vomiting.

X
Disseminated intravascular coagulation (DIC): a serious disorder of blood clotting resulting in the widespread formation of blood clots and internal bleeding.X
Sudden death
SERIOUS SIDE EFFECTS, HOW OFTEN THEY HAPPEN AND WHAT TO DO ABOUT THEM
Symptom / effectTalk to your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases
Serious Skin Reactions (Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis): any combination of red itchy rash with blisters and peeling of the skin and /or of the lips, eyes, mouth, nasal passages or genitals. It often goes with fever, chills, headache, cough, body aches or joint pain. You may have dark urine, yellow skin or eyes.X
Atrial fibrillation (irregular heart beat): dizziness, palpitations, racing heartbeat.X
Pneumonia: productive cough, chest pain, difficulty breathing, fever.X
Sepsis that can lead to death: fever with a racing heartbeat, rapid shallow breathing, cold, pale, clammy or mottled skin and/or confusion.X

UNKNOWN FREQUENCY

Interstitial lung disease:

Breathing problems including persistent cough and/or shortness of breath.

X

This is not a complete list of side effects. For any unexpected effects while taking HALAVEN, contact your doctor or pharmacist.

HOW TO STORE IT

Store up to 25°C. Excursions permitted to 30°C.

Do not freeze.

REPORTING SUSPECTED SIDE EFFECTS

You can report any suspected adverse reactions associated with the use of health products to the Canada Vigilance Program by one of the following 3 ways:

  • Report online at www.healthcanada.gc.ca/medeffect
  • Call toll-free at 1-866-234-2345
  • Complete a Canada Vigilance Reporting Form and:

    • Fax toll-free to 1-866-678-6789, or
    • Mail to: Canada Vigilance Program

      Health Canada

      Postal Locator 0701E

      Ottawa, Ontario

      K1A 0K9

Postage paid labels, Canada Vigilance Reporting Form and the adverse reaction reporting guidelines are available on the MedEffect™ Canada Web site at www.healthcanada.gc.ca/medeffect.

NOTE: Should you require information related to the management of the side effect, contact your health professional. The Canada Vigilance Program does not provide medical advice.

MORE INFORMATION

This document plus the full product monograph, prepared for health professionals can be found by contacting the sponsor, Eisai Limited, at: 1-877-873-4724.

Last revised: August 4, 2017

HALAVEN® is a trademark owned by Eisai R&D Management Co., Ltd.

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02377438

Revision date stated in the text: August 4, 2017

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Halaven

Rx or OTC
Prescription (Rx)?
DIN 02377438
Schedule(s) PRESCRIPTION
Active ingredient(s) Eribulin mesylate 0.5 MG
Dosage form(s) Solution
Route(s) of administration Intravenous
Drug class (WHO ATC)
  1. L Antineoplastic and immunomodulating agents
    1. L01 Antineoplastic agents
      1. L01X Other antineoplastic agents
        1. L01XX Other antineoplastic agents
          1. L01XX41 Eribulin
Company EISAI LIMITED
Current status Marketed
Current status date March 19, 2012

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.